Law firms and in-house counsel have mastered the use of remote-work tools to handle even the most complex legal challenges. This fundamental, global transformation in the legal workplace has created an unprecedented opportunity to lower the high cost of traditional “big firm” IP legal services in the U.S. Gemini was created to exploit this opportunity. Our lawyers, who are among the most experienced and successful at helping manufacturers of biosimilar, biobetter, generic and 505(b)(2) products navigate IP barriers to access the U.S. market, work remotely with very little overhead and pass the savings onto our clients. This innovative approach can lower costs by as much as 50% over conventional, highly-qualified firms. Where “big firm” infrastructure provides a tactical advantage, such as complex district court patent infringement trials, our collaborations with top AmLaw 50 firms enable us to offer seamless, fully-integrated trial teams and budgets that leverage lower-cost Gemini resources as much as possible. This flexible and collaborative approach means that our clients have access to the infrastructure to handle the most complex litigation when needed, but don’t have to pay for that infrastructure
when it’s not.